|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 7/64 | |
| A61K 38/13 | |||
| A61P 27/02 |
| (11) | Number of the document | 2714720 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12724525.6 |
| Date of filing the European patent application | 2012-05-25 | |
| (97) | Date of publication of the European application | 2014-04-09 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/039611 |
| Date | 2012-05-25 |
| (87) | Number | WO 2012/166610 |
| Date | 2012-12-06 |
| (30) | Number | Date | Country code |
| 201161490887 P | 2011-05-27 | US |
| (72) |
KARAMI, Kiomars, US
GRAHAM, Richard S., US
GORE, Anuradha V., US
SMITH, Scott W., US
WU, Ke, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | A CRYSTALLINE FORM OF CYCLOSPORINE A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF |
| A CRYSTALLINE FORM OF CYCLOSPORINE A, METHODS OF PREPARATION, AND METHODS FOR USE THEREOF |